等待开盘 08-23 09:30:00 美东时间
-0.160
-4.36%
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
07-02 20:06
Genenta Science has reported positive results from its ongoing GBM trial, with two patients now qualifying for long-term follow-up and surviving three years post-surgery. One patient remains progression-free without second-line therapy, while the other’s disease progression stabilized. For uMGMT-GBM patients, the two-year survival rate remains at 29% with a median OS of 17 months, compared to historical 14% and 13-15 months. The TEM-GU Phase 1 st...
07-01 09:00
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 27, 2025 /PRNewswire/ -- USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has com...
02-27 23:04
Genenta Science SpA Sponsored ADR ( ($GNTA) ) just unveiled an announcement. Ge...
2024-12-31 05:27
Unity Software(U.US) reported fourth-quarter financial results after the market...
2024-05-13 17:49
Genenta Science SpA Sponsored ADR (GNTA) has released an update. Genenta Scienc...
2024-05-04 05:28
Genenta Science SpA Sponsored ADR (GNTA) has released an update. Genenta Scienc...
2024-04-27 06:27
Genenta Science SpA Sponsored ADR (GNTA) has released an update. Genenta Scienc...
2024-04-09 05:27
Roth MKM analyst Kumaraguru Raja assumes Genenta Science (NASDAQ:GNTA) with a Buy rating and announces Price Target of $15.
2023-06-29 21:21
Genenta Science S.p.A. (NASDAQ:GNTA – Get Rating)'s share price shot up 3.9% du...
2023-03-03 13:52